Editorial: Bioengineered gene and cell therapy for treating cardiovascular diseases

• Kai Wang,
• Xujie Liu,
• Xiaojun Lance Lian,
• Xiaojun Lance Lian,
• Xiaoping Bao,
• Kailong Li

Affiliations

Kai Wang

State Key Laboratory of Vascular Homeostasis and Remodeling, Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China

Xujie Liu

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Beijing, China

Xiaojun Lance Lian

Department of Biomedical Engineering, The Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, United States

Xiaojun Lance Lian

Department of Biology, The Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, United States

Xiaoping Bao

Davdidson School of Chemical Engineering, Purdue University, West Lafayette, IN, United States

Kailong Li

Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Biophysics, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China